Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Gut

• Publication date

  1999-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.45.4.489PMID 10486353PMCID PMC1727665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Squamous Islands in Barrett's Esophagus: What Lies Underneath?

  1998cited by this paper
• Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.

  1997cited by this paper
• Photothermal laser ablation of Barrett’s oesophagus: endoscopic and histological evidence of squamous re-epithelialisation

  1997cited by this paper
• Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.

  1996cited by this paper
• Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

  1996cited by this paper
• Photodynamic therapy for Barrett's esophagus: clinical update.

  1996cited by this paper
• The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.

  1995cited by this paper
• Quantitative endoscopy: precise computerized measurement of metaplastic epithelial surface area in Barrett's esophagus.

  1995cited by this paper
• Controlled trial of reversal of Barrett's esophagus with acid suppression and multi-polar electrocoagulation (MPEC)

  1995cited by this paper
• Long term continuous omeprazole treatment of patients with Barrett's oesophagus

  1995cited by this paper
• Risk factors for Barrett's oesophagus: a life history approach to behavioural assessment in the distant past

  1995cited by this paper
• Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

  1994cited by this paper
• Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.

  1994cited by this paper
• Mucosal sensitivity and salivary response to infused acid in patients with columnar‐lined oesophagus

  1994cited by this paper
• Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium.

  1993cited by this paper
• Risk factors for the development of an adenocarcinoma in columnar‐lined (Barrett) esophagus

  1993cited by this paper
• Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy

  1993cited by this paper
• Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma.

  1992cited by this paper
• Barrett's esophagus and risk of adenocarcinoma.

  1991cited by this paper
• [Regression of cylindrical epithelial metaplasia in Barrett esophagus].

  1990cited by this paper
• Regression of Barrett's epithelium with omeprazole.

  1989cited by this paper
• Esophageal acid clearance during sleep in patients with Barrett's esophagus

  1988cited by this paper
• Famotidine: effective treatment of Zollinger-Ellison syndrome.

  1987cited by this paper
• Esophageal acid sensitivity in Barrett's esophagus.

  1987cited by this paper
• Adenocarcinoma and Barrett's esophagus. An overrated risk?

  1984cited by this paper
• The histologic spectrum of Barrett's esophagus.

  1976cited by this paper

• Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.

  2025cites this paper
• Predicting Regression of Barrett’s Esophagus—Can All the King’s Men Put It Together Again?

  2024cites this paper
• Variation in Fatty Acid Synthase, Ki67 and p53 Esophageal Mucosa Expressions in Barrett’s Esophagus Patients Treated for One Year with Two Esomeprazole Different Regimens

  2023cites this paper
• Intestinal metaplasia in follow-up endoscopies among Asian patients with short-segment Barrett's esophagus: Regression, sampling error, and associated factors.

  2023cites this paper
• Management of Long-Segment Barrett's Esophagus

  2023cites this paper
• Quality in Barrett's Esophagus: Diagnosis and Management

  2022cites this paper
• Cancer Prevention in Patients with GERD and Barrett’s Esophagus—Medicine

  2021cites this paper
• Barrett’s Epithelium to Esophageal Adenocarcinoma: Is There a “Point of No Return”?

  2021cites this paper
• Chemoprevention of Esophageal Cancer

  2019cites this paper
• Gastrointestinal Cancer Prevention: Diet, Lifestyle, and Therapeutic Prevention

  2019cites this paper
• Elective surveillance gastroscopy in Barrett's oesophagus: a case study and review of the clinical endoscopist's role

  2018cites this paper
• Critical appraisal of guidelines for screening and surveillance of Barrett's esophagus.

  2018cites this paper
• Пищевод Баррета: современные возможности диагностики, терапии и снижения риска развития рака

  2017cites this paper
• Esophageal Adenocarcinoma : Pathogenesis, Prevention, and Prognosis

  2017cites this paper
• Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer

  2017cites this paper
• Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma.

  2017cites this paper
• Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?

  2017cites this paper
• Barrett's esophagus: best practices for treatment and post-treatment surveillance.

  2017cites this paper
• Guía de diagnóstico y tratamiento del esófago de Barrett. Tratamiento médico, quirúrgico y endoscópico Guías de diagnóstico y tratamiento en gastroenterología

  2016cites this paper
• Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?

  2016cites this paper
• The Role of Esophagogastroduodenoscopy Surveillance for Patients with Barrett Esophagus.

  2016cites this paper
• Management of Barrett's oesophagus Barrett's oesophagus is associated with the development of oesophageal adenocarcinoma. This review highlights the management strategies currently used in the treatment of this condition.

  2016cites this paper
• The Role of Drugs and Nutrition in the Prevention of Esophageal Adenocarcinoma Associated with Barrett’s Esophagus

  2016cites this paper
• Trajectories of endoscopic Barrett esophagus: Chronological changes in a community-based cohort

  2016cites this paper
• Management of Barrett's oesophagus.

  2016cites this paper
• The Columnar Lined Esophagus: aspects on the assessment of dysplasia and on the relationship with the esophageal submucosal glands

  2015cites this paper
• Chemoprevention for Esophageal Carcinoma

  2015cites this paper
• Identification of Two Novel Genome-Wide Significant Single Nucleotide Polymorphisms, associated with Barrett’s Oesophagus, determined by further Replication of a Genome-Wide Association Study

  2015cites this paper
• Barrett's oesophagus length is established at the time of initial endoscopy and does not change over time: results from a large multicentre cohort

  2015cites this paper
• Medical management of Barrett's esophagus

  2015cites this paper
• Acid suppression and surgical therapy for Barrett's oesophagus.

  2015cites this paper
• Long segments of columnar-lined lower esophagus are not always metaplastic.

  2015cites this paper
• Does Barrett's Esophagus Regress after Surgery (or Proton Pump Inhibitors)

  2014cites this paper
• Barrett’s Esophagus: Treatment Options and Management

  2014cites this paper
• Reflux composition influences the level of NF‐κB activation and upstream kinase preference in oesophageal adenocarcinoma cells

  2014cites this paper
• Changing Epidemiology of Esophageal Cancers Worldwide - What Do We Learn?

  2014cites this paper
• Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.

  2014cites this paper
• Barrett’s Esophagus

  2014cites this paper
• Embryological signaling pathways in Barrett's metaplasia development and malignant transformation; mechanisms and therapeutic opportunities.

  2014cites this paper
• Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

  2014cites this paper
• Oesophageal Cancer : strategies to improve outcomes, and identify novel immunological biomarkers and targets

  2014influential citation
• Carcinogenesis of Barrett’s esophagus: a review of the clinical literature

  2013cites this paper
• British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

  2013cites this paper
• Association between obesity and Barrett’s esophagus in a Japanese population: a hospital-based, cross-sectional study

  2013cites this paper
• Barrett's oesophagus: epidemiology, cancer risk and implications for management

  2013cites this paper
• Long term proton pump inhibitor (PPI) use and incidence of gastric premalignant lesions

  2013cites this paper
• Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus.

  2013cites this paper
• Laparoscopic Nissen fundoplication in the treatment of Barrett's esophagus – 10 years of experience

  2013cites this paper
• Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea

  2013cites this paper
• Managing Barrett’s esophagus with radiofrequency ablation

  2013cites this paper
• Barrett’s to Oesophageal Cancer Sequence: A Model of Inflammatory-Driven Upper Gastrointestinal Cancer

  2012cites this paper
• INGUINAL AND MESENTERIC LYMPH NODES IN CONDITIONS OF GROWTH OF EXPERIMENTAL MALIGNANT TUMOR IN THE RECTUM

  2012cites this paper
• Barrett’s Oesophagus

  2012cites this paper
• Qualitätssicherung der endoskopischen Überwachung des Barrettösophagus

  2012cites this paper
• Management strategies of Barrett's esophagus

  2012cites this paper
• Management of Barrett’s oesophagus and intramucosal oesophageal cancer: a review of recent development

  2012cites this paper
• Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?

  2012cites this paper
• 5. Barrett's Oesophagus

  2012cites this paper
• COX‐2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor

  2012cites this paper
• The Role of Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease

  2012cites this paper
• Effective Intra-Esophageal Acid Control Is Associated with Improved Radiofrequency Ablation Outcomes in Barrett’s Esophagus

  2012cites this paper
• Submucosal glands in the columnar‐lined oesophagus: evidence of an association with metaplasia and neosquamous epithelium

  2012cites this paper
• Proton Pump Inhibitors: The Good, the Bad, and the Unwanted

  2012cites this paper
• Potent Gastric Acid Inhibition in the Management of Barrett’s Oesophagus

  2012cites this paper
• Treatment of Barrett's Esophagus

  2012cites this paper
• Management strategies of Barrett's esophagus.

  2012cites this paper
• Acid suppression increases rates of Barrett's esophagus and esophageal injury in the presence of duodenal reflux.

  2012cites this paper
• Molecular biomarkers and ablative therapies for Barrett’s esophagus

  2012cites this paper
• [Surveillance in Barrett's esophagus].

  2011cites this paper
• Impact of Academic Detailing on Proton Pump Inhibitor Prescribing Behaviour in a Community Hospital

  2011cites this paper
• Chemoprevention in Barrett's oesophagus.

  2011cites this paper
• Does fundoplication really reduce deoxyribonucleic acid methylation of Barrett esophagus?

  2011cites this paper
• The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis

  2011cites this paper
• Time for a (re) definition of (recurrent) sigmoid diverticulitis?

  2011cites this paper
• Barrett’s Esophagus: A Review of the Literature

  2011cites this paper
• Diseases of the Digestive Tract: Is Prevention Possible and Feasible?

  2011cites this paper
• Barrett's esophagus: natural history

  2011cites this paper
• DOES SHORT‐SEGMENT COLUMNAR‐LINED ESOPHAGUS ELONGATE DURING A MEAN FOLLOW‐UP PERIOD OF 5.7 YEARS?

  2011cites this paper
• WITHDRAWN: Gastric foveolar metaplasia in the duodenum-the contravener may have escaped-Reply.

  2011cites this paper
• Optimal management of Barrett’s esophagus: pharmacologic, endoscopic, and surgical interventions

  2011cites this paper
• Barrett's esophagus in children: does it need more attention?

  2011cites this paper
• Role of Acid Suppression in the Development and Progression of Dysplasia in Patients with Barrett’s Esophagus

  2011cites this paper
• Aberrant DNA methylation in oesophageal cancer and Barrett’s oesophagus.

  2010cites this paper
• Kuipers gastrin : the fog is clearing Barrett ' s oesophagus , proton pump inhibitors and

  2010cites this paper
• Cell Cycle Deregulation in Pre-neoplasia: Case Study of Barrett’s Oesophagus

  2010cites this paper
• Guía de diagnóstico y tratamiento del esófago de Barrett. Tratamiento médico, quirúrgico y endoscópico

  2010cites this paper
• Treatment for Barrett's oesophagus.

  2010cites this paper
• Treatment of GERD complications (Barrett's, peptic stricture) and extra-oesophageal syndromes.

  2010cites this paper
• 3. Barrett's Esophagus

  2010cites this paper
• Endoscopic eradication of Barrett's esophagus.

  2010cites this paper
• Management of esophageal cancer.

  2010cites this paper
• Chapter 7 – Barrett's Esophagus

  2010cites this paper
• 57 – Benign Esophageal Disease

  2010cites this paper
• The effects of high‐dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett’s oesophagus

  2010cites this paper
• Endoscopic mucosal or submucosal resection of early neoplasia in Barrett's esophagus after antireflux surgery.

  2010cites this paper
• Barrett's oesophagus, proton pump inhibitors and gastrin: the fog is clearing

  2010cites this paper
• Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases

  2010cites this paper
• Gastro-esophageal Reflux

  2009cites this paper
• The potential impact of contemporary developments in the management of patients with gastroesophageal reflux disease undergoing an initial gastroscopy.

  2009cites this paper
• Barrett’s Esophagus Revisited: Epidemiology, Risk Stratification and Cancer Prevention

  2009cites this paper